Detalhe da pesquisa
1.
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds.
Cell
; 167(1): 260-274.e22, 2016 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27641504
2.
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screens.
Mol Syst Biol
; 16(7): e9405, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32627965
3.
A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization.
Cancer Cell
; 42(2): 301-316.e9, 2024 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215750
4.
Integrated cross-study datasets of genetic dependencies in cancer.
Nat Commun
; 12(1): 1661, 2021 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33712601
5.
Erratum to: Drug Sensitivity Assays of Human Cancer Organoid Cultures.
Methods Mol Biol
; 1576: 353, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30006863
6.
Drug Sensitivity Assays of Human Cancer Organoid Cultures.
Methods Mol Biol
; 1576: 339-351, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-27628132
7.
Corrigendum: High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer.
Sci Data
; 5: 180215, 2018 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30299440
8.
Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics.
Nat Commun
; 9(1): 2983, 2018 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30061675
9.
High-throughput RNAi screen for essential genes and drug synergistic combinations in colorectal cancer.
Sci Data
; 4: 170139, 2017 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28972570